Literature DB >> 31579073

Causal associations of autoimmune thyroiditis and papillary thyroid carcinoma: mRNA expression of selected nuclear receptors and other molecular targets.

Dana Macejova1, Jan Podoba2, Lucia Toporova1, Marianna Grigerova2, Karol Kajo3, Katarina Machalekova3, Julius Brtko1.   

Abstract

Potential causal associations of autoimmune thyroiditis (AIT) and papillary thyroid carcinoma (PTC) have been studied previously. The mRNA expression patterns of thyroid hormone receptors (TR), retinoid receptors (RAR), rexinoid receptors (RXR), dihydroxyvitamin D3 receptors (VDR), and progesterone receptors (PR) in PTC tissue of patients without autoimmune thyroiditis (PTC/AIT-) and in PTC tissue of patients with coexisting AIT (PTC/AIT+) have been investigated in order to judge whether the observed changes may take part in the promotion and progression of thyroid cancer. Tumours with or without AIT were classified histologically and the semiquantitative PCR was performed. The results revealed that there was decreased expression of TRα, TRβα, RARα and PR mRNA in PTC/AIT+ tumours when compared with PTC/AIT- tumours. Decreased expression of RARα in PTC/AIT+ was detected when compared with PTC/AIT- patients. A similar effect of AIT was observed with a decrease in RARγ expression in PTC/AIT+ patients. On the other hand, there was an increased expression of VDR in thyroid tumours (PTC/AIT+) when compared with PTC/AIT-. PR mRNA was decreased in the thyroid tumours of PTC/AIT+ patients when compared with PTC/AIT- patients. In addition, there was an increased expression of MKi67 and complement C3 in PTC of PTC/AIT+ when compared with PTC/AIT-. In the PTC/AIT+ group, a decreased level of IGF-1 mRNA was found when compared with the PTC/AIT- group. According to the significant differences of the studied markers in PTC/AIT+ compared with PTC/AIT-, it was indicated that AIT may be a predisposing factor for the development of PTC.
Copyright © 2019, Spandidos Publications.

Entities:  

Keywords:  autoimmune thyroiditis; causality; nuclear receptors; papillary thyroid carcinoma; reverse transcription-semiquantitative PCR

Year:  2019        PMID: 31579073      PMCID: PMC6757255          DOI: 10.3892/ol.2019.10770

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  34 in total

1.  Malignant Triton tumour exhibits a complete expression pattern of nuclear retinoid and rexinoid receptor subtypes.

Authors:  Július Brtko; Daniela Sejnová; Slavomíra Ondková; Dana Macejová
Journal:  Gen Physiol Biophys       Date:  2009-12       Impact factor: 1.512

2.  Cyclooxygenase-2 expression in human thyroid carcinoma and Hashimoto's thyroiditis.

Authors:  Anthony J Cornetta; John P Russell; Mary Cunnane; William M Keane; Jay L Rothstein
Journal:  Laryngoscope       Date:  2002-02       Impact factor: 3.325

Review 3.  Nuclear receptors in cancer - uncovering new and evolving roles through genomic analysis.

Authors:  Vineet K Dhiman; Michael J Bolt; Kevin P White
Journal:  Nat Rev Genet       Date:  2017-12-27       Impact factor: 53.242

4.  Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis.

Authors:  Salvatore Vaccarella; Silvia Franceschi; Freddie Bray; Christopher P Wild; Martyn Plummer; Luigino Dal Maso
Journal:  N Engl J Med       Date:  2016-08-18       Impact factor: 91.245

5.  Functional retinoid and thyroid hormone receptors in human thyroid-carcinoma cell lines and tissues.

Authors:  C schmutzler; J Brtko; R Winzer; T C Jakobs; J Meissner-Weigl; D Simon; P E Goretzki; J Köhrle
Journal:  Int J Cancer       Date:  1998-05-04       Impact factor: 7.396

6.  Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma.

Authors:  K C Loh; F S Greenspan; F Dong; T R Miller; P P Yeo
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

7.  Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies.

Authors:  Wensen Chen; Sumin Wang; Tian Tian; Jianling Bai; Zhibin Hu; Yan Xu; Jing Dong; Feng Chen; Xinru Wang; Hongbing Shen
Journal:  Eur J Hum Genet       Date:  2009-06-03       Impact factor: 4.246

8.  Thyroid hormone deiodinases and cancer.

Authors:  Sabina Casula; Antonio C Bianco
Journal:  Front Endocrinol (Lausanne)       Date:  2012-06-01       Impact factor: 5.555

9.  Immunohistochemical expression of ER-α and PR in papillary thyroid carcinoma.

Authors:  Marwa Mohammed Serag Eldien; Asmaa Gaber Abdou; Tarek Rageh; Eman Abdelrazek; Enas Elkholy
Journal:  Ecancermedicalscience       Date:  2017-06-13

10.  Isotretinoin as a Possible Environmental Trigger to Autoimmunity in Genetically Susceptible Patients.

Authors:  Jocelyn Nugroho; Bahareh Schweiger
Journal:  Case Rep Pediatr       Date:  2017-03-26
View more
  3 in total

1.  Preparation of a miR-155-activating nucleic acid nanoflower to study the molecular mechanism of miR-155 in inflammation.

Authors:  Wenxin Wang; Jie Geng; Xiaohan Wu; Jianguang Zhang; Chenna Zheng; Huachun Rao; Tianyu Li; Yong Diao; Huiyong Yang
Journal:  Mol Med       Date:  2022-06-17       Impact factor: 6.376

2.  Effects of Selenium Supplement on B Lymphocyte Activity in Experimental Autoimmune Thyroiditis Rats.

Authors:  Yang Li; Xinhe Zuo; Chuan Hua; Yong Zhao; Xun Pei; Man Tian
Journal:  Int J Endocrinol       Date:  2021-08-10       Impact factor: 3.257

Review 3.  Pro-Arrhythmic Signaling of Thyroid Hormones and Its Relevance in Subclinical Hyperthyroidism.

Authors:  Narcis Tribulova; Lin Hai Kurahara; Peter Hlivak; Katsuya Hirano; Barbara Szeiffova Bacova
Journal:  Int J Mol Sci       Date:  2020-04-19       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.